BILI Stock Analysis: Bilibili | NASDAQ
Internet Content & Information | NASDAQ, USA | Market Cap: 5.692m USD | 12M Return: -54.3% | US0900401060 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 43.2M
Qual. Beats: 0
Rev. Trend: 98.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.6 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Bilibili Inc. (NASDAQ: BILI) is a Shanghai-based online entertainment platform founded in 2009 that targets Chinas younger digital audience, commonly referred to as the Z+ generation. Its core business revolves around a video community built on professional user-generated videos (PUGV), which forms the foundation of its engagement-driven model. The company generates revenue across multiple streams, including mobile games, value-added services (live broadcasting, premium memberships, comics via Bilibili Comic, audio dramas on Maoer, and paid courses), advertising, and IP-related merchandise and e-commerce.
As a player in the Interactive Home Entertainment sub-industry, Bilibili operates within Chinas tightly regulated digital media environment, where gaming licenses, content censorship, and minor-protection rules significantly shape monetization. Its community-centric approach-combining free ad-supported content with premium subscriptions, virtual gifting, and game publishing-reflects the broader trend among Chinese internet platforms of layering multiple monetization models on top of a single user base to convert engagement into revenue.
- Mobile games revenue growth driven by new title launches
- Advertising monetization scales with rising user engagement
- China gaming approvals and content regulations limit new releases
- Operating margin improvement hinges on content cost leverage
- Competition from Douyin and Kuaishou pressures user growth
| Net Income: 1.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.54 > 1.0 |
| NWC/Revenue: 21.72% < 20% (prev 32.53%; Δ -10.80% < -1%) |
| CFO/TA 0.17 > 3% & CFO 7.15b > Net Income 1.53b |
| Net Debt (-14.6b) to EBITDA (3.90b): -3.75 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (453.6m) vs 12m ago 3.71% < -2% |
| Gross Margin: 37.25% > 18% (prev 35.91%; Δ 1.34% > 0.5%) |
| Asset Turnover: 76.85% > 50% (prev 75.74%; Δ 1.12% > 0%) |
| Interest Coverage Ratio: 10.81 > 6 (EBIT TTM 1.71b / Interest Expense TTM 158.5m) |
| A: 0.16 (Total Current Assets 28.2b - Total Current Liabilities 21.4b) / Total Assets 42.5b |
| B: -0.62 (Retained Earnings -26.5b / Total Assets 42.5b) |
| C: 0.04 (EBIT TTM 1.71b / Avg Total Assets 40.6b) |
| D: 0.60 (Book Value of Equity 16.0b / Total Liabilities 26.6b) |
| Altman-Z'' = -0.07 = B |
| DSRI: 0.73 (Receivables 1.68b/2.18b, Revenue 31.2b/29.4b) |
| GMI: 0.96 (GM 35.91% / 37.25%) |
| AQI: 0.89 (AQ_t 0.29 / AQ_t-1 0.33) |
| SGI: 1.06 (Revenue 31.2b / 29.4b) |
| TATA: -0.13 (NI 1.53b - CFO 7.15b) / TA 42.5b) |
| Beneish M = -3.32 (Cap -4..+1) = AA |
As of November 18, 2026, the stock is trading at USD 11.94 with a total of 3,557,863 shares traded. Over the past week, the price has changed by -16.15%, over one month by -14.78%, over three months by -30.70% and over the past year by -54.29%.
Current recommended Stop Loss: 11.30 (which is 5.4% or 1.3 ATR below the current price).
Bilibili has received a consensus analysts rating of 4.73. Therefore, it is recommended to buy BILI.
- StrongBuy: 23
- Buy: 6
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 25.3 | 112.2% |
Market Cap CNY = 37.9b (5.69b USD * 6.66455 USD.CNY)
P/E Trailing = 27.9216
P/E Forward = 11.1607
P/S = 0.1812
P/B = 2.3936
P/EG = 0.3042
Revenue TTM = 31.2b CNY
EBIT TTM = 1.71b CNY
EBITDA TTM = 3.90b CNY
Long Term Debt = 4.64b CNY (from longTermDebt, last quarter)
Short Term Debt = 4.88b CNY (from shortTermDebt, last quarter)
Debt = 9.67b CNY (from shortLongTermDebtTotal, last quarter) + Leases 149.3m
Net Debt = -14.6b CNY (calculated: Debt 9.67b - CCE 24.3b)
Enterprise Value = 23.3b CNY (37.9b + Debt 9.67b - CCE 24.3b)
Interest Coverage Ratio = 10.81 (Ebit TTM 1.71b / Interest Expense TTM 158.5m)
EV/FCF = 4.38x (Enterprise Value 23.3b / FCF TTM 5.32b)
FCF Yield = 22.84% (FCF TTM 5.32b / Enterprise Value 23.3b)
FCF Margin = 17.03% (FCF TTM 5.32b / Revenue TTM 31.2b)
Net Margin = 4.89% (Net Income TTM 1.53b / Revenue TTM 31.2b)
Gross Margin = 37.25% ((Revenue TTM 31.2b - Cost of Revenue TTM 19.6b) / Revenue TTM)
Gross Margin QoQ = 37.73% (prev 37.11%)
Tobins Q-Ratio = 0.55 (Enterprise Value 23.3b / Total Assets 42.5b)
Interest Expense / Debt = 1.64% (Interest Expense 158.5m / Debt 9.67b)
Taxrate = 1.99% (30.8m / 1.55b)
NOPAT = 1.68b (EBIT 1.71b * (1 - 1.99%))
Current Ratio = 1.32 (Total Current Assets 28.2b / Total Current Liabilities 21.4b)
Debt / Equity = 0.61 (Debt 9.67b / totalStockholderEquity, last quarter 16.0b)
Debt / EBITDA = -3.75 (Net Debt -14.6b / EBITDA 3.90b)
Debt / FCF = -2.75 (Net Debt -14.6b / FCF TTM 5.32b)
Total Stockholder Equity = 15.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.76% (Net Income 1.53b / Total Assets 42.5b)
RoE = 9.85% (Net Income TTM 1.53b / Total Stockholder Equity 15.5b)
RoCE = 8.51% (EBIT 1.71b / Capital Employed (Equity 15.5b + L.T.Debt 4.64b))
RoIC = 6.88% (NOPAT 1.68b / Invested Capital 24.4b)
WACC = 7.94% (E(37.9b)/V(47.6b) * Re(9.56%) + D(9.67b)/V(47.6b) * Rd(1.64%) * (1-Tc(0.02)))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 92.58 | Cagr: 4.00%
[DCF] Terminal Value 77.97% ; FCFF base≈4.90b ; Y1≈5.61b ; Y5≈8.26b
[DCF] Fair Price = 434.1 (EV 124b - Net Debt -14.6b = Equity 139b / Shares 320.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.10 | # QB: 0
Revenue Correlation: 98.05 | Revenue CAGR: 14.87% | SUE: -0.00 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.79 | Chg30d=-0.87% | Revisions=-17% | Analysts=13
EPS current Year (2026-12-31): EPS=6.70 | Chg30d=-1.69% | Revisions=-67% | GrowthEPS=+14.0% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=8.47 | Chg30d=-1.90% | Revisions=-62% | GrowthEPS=+26.4% | GrowthRev=+10.6%
[Analyst] Revisions Ratio: -71% (up=1, down=13)